A 60-year-old woman donated a kidney to her son, nearly a decade after giving him a part of her liver. The organ donation took place at the Institute of Liver and Biliary Sciences (ILBS), New Delhi.

A new antivenom relies on antibodies from the blood of Tim Friede, who immunized himself against snakebites by injecting increasing doses of venom into his body.

In the long battle to create an effective HIV vaccine, scientists have made a major leap forward. A new study shows that a ...

An ICMR-funded trial led by CMC Vellore demonstrated that CAR-T therapy, which uses a patient’s own T cells to fight cancer, can be safely manufactured at the hospital and infused to treat patients in ...

Coherus BioSciences, Inc.’s CHRS share price has surged by 6.25%, which has investors questioning if this is right time to sell.

Blood from a former construction and factory worker — and self-taught herpetologist — could hold the key to a universal antivenom.

It also develops CTX-10726, a bispecific antibody that targets PD-1 and VEFG-A ... Click the button below to subscribe to A+ Investor and get access to everything you need to know about Compass ...

Their new study identifies powerful antibodies capable of neutralizing a wide range of norovirus strains. The finding could lead to the design of broadly effective norovirus vaccine, as well as ...

Monoclonal antibodies have specificity for a particular antigen (target of antibodies), but polyclonal ones are not specific to any antigen. Recombinant ones are monoclonal, and here are the key ...

Monoclonal antibodies (mAbs) are manufactured proteins that behave similarly to antibodies found naturally in the body. Researchers initially developed them for treating certain cancers but have ...

Usually, monoclonal antibodies are developed from the antibodies of patients who have recovered from an infection, or they are designed to recognise and target a particular antigen. For example ...